This PGD template supports the provision of additional meningococcal group A, C, W and Y conjugate vaccine to individuals with underlying medical conditions. It is valid from 1 March 2017 to 28 February 2019.
The template requires further authorisation by an appropriate authorising person, relating to the class of person by whom product is to be supplied, in accordance with the Human Medicines Regulations 2012 (HMR). This may be a clinical governance or patient safety lead, who has designated responsibility for signing PGDs on behalf of the authorising body. The PGD is not legal or valid without signed authorisation in accordance with HMR 2012 schedule 16 part 2.
Adoption and governance of the use of this PGD is the responsibility of the authorising organisation and provider.
Provider organisations, health professionals and immunisation practitioners should check they are working to the current PGD versions and only work to documents authorised in accordance with HMR 2012 schedule 16 part 2.
These PGDs should be used with reference to the Green Book, and Summary of Product Characteristics for the vaccine.